Ardelyx, Inc. (ARDX) vs Cytek Biosciences, Inc. (CTKB)
A side-by-side comparison of Ardelyx, Inc. and Cytek Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARDX
Ardelyx, Inc.
$3.32HealthcareDelayed quote: Oct 6, 2026, 10:00 AM EDT
CTKB
Cytek Biosciences, Inc.
$5.98HealthcareDelayed quote: Oct 6, 2026, 10:00 AM EDT
Total return — ARDX vs CTKB
growth of $100 · dividends reinvested · last 5yARDX +75.6% (+11.9%/yr)CTKB -67.5% (-20.1%/yr)ARDX compounded faster over this window
Log scale — wide-divergence pair
ARDX CTKB
ARDX vs CTKB: by the numbers
- •ARDX is the larger company ($819M vs $772M market cap).
- •Both run net losses; ARDX's is the smaller (-12.35% vs -38.98% net margin).
- •ARDX grew revenue faster over the past five years (105.14% vs 13.37% CAGR).
Metrics side by side
Valuation
| Metric | ARDX | CTKB |
|---|---|---|
| P/S ratio | 1.82 | 3.74 |
| P/B ratio | 5.50 | 2.40 |
Profitability
| Metric | ARDX | CTKB |
|---|---|---|
| Gross margin | 93.96% | 53.23% |
| Operating margin | -7.86% | -21.60% |
| Net margin | -12.35% | -38.98% |
| ROE | -37.38% | -25.03% |
| ROIC | -7.99% | -12.00% |
Growth (annualized)
| Metric | ARDX | CTKB |
|---|---|---|
| Revenue CAGR (5Y) | 105.14% | 13.37% |
| Total return CAGR (5Y) | 20.95% | -23.16% |
Frequently asked
- Which has grown faster, ARDX or CTKB?
- Over the past five years, ARDX grew revenue faster — ARDX at a 105.14% CAGR versus CTKB at 13.37%.
- How have ARDX and CTKB total returns compared?
- Over the past 5 years, ARDX delivered 20.95% and CTKB delivered -23.16% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Ardelyx ROECytek Biosciences ROEArdelyx operating marginCytek Biosciences operating marginArdelyx revenue growthCytek Biosciences revenue growthArdelyx free cash flowCytek Biosciences free cash flow
Ardelyx & Cytek Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.